Dekkers, Koen F. https://orcid.org/0000-0002-4074-7235
Sayols-Baixeras, Sergi https://orcid.org/0000-0002-1181-6262
Baldanzi, Gabriel https://orcid.org/0000-0003-3962-3953
Nowak, Christoph https://orcid.org/0000-0001-8435-3978
Hammar, Ulf
Nguyen, Diem https://orcid.org/0000-0002-9680-5772
Varotsis, Georgios https://orcid.org/0000-0002-3320-2448
Brunkwall, Louise
Nielsen, Nynne
Eklund, Aron C. https://orcid.org/0000-0003-0861-1001
Bak Holm, Jacob https://orcid.org/0000-0003-1756-0875
Nielsen, H. Bjørn https://orcid.org/0000-0003-2281-5713
Ottosson, Filip https://orcid.org/0000-0002-8312-3545
Lin, Yi-Ting
Ahmad, Shafqat
Lind, Lars
Sundström, Johan https://orcid.org/0000-0003-2247-8454
Engström, Gunnar
Smith, J. Gustav
Ärnlöv, Johan
Orho-Melander, Marju https://orcid.org/0000-0002-3578-2503
Fall, Tove https://orcid.org/0000-0003-2071-5866
Article History
Received: 8 February 2022
Accepted: 26 August 2022
First Online: 23 September 2022
Change Date: 23 May 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-023-38607-1
Competing interests
: N.N., A.C.E., J.B.H., and H.B.N. are employees of Clinical Microbiomics. J.Ä. has served on advisory boards for AstraZeneca and Boehringer Ingelheim and has received lecturing fees from AstraZeneca and Novartis, all unrelated to the present project. The remaining authors declare no competing interests.